BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fundamental differences, and how we are pressing forward with our clinical trial programs, continued research and market development.The distinct advantages and characteristics of our product and part of the fundamental differences are it's oral delivery, and safety because of the low dose. Our product dose is only 1/20,000 (one twenty thousandth) of the typical injectable dose. We are committed to bringing low-dose oral interferon and it's many distinct advantages to a worldwide marketplace. "Good ideas are not adopted automatically. They must be driven into practice with courageous patience."


Contact Details:
4134 Business Park Drive Amarillo
Amarillo
79110
United States of America
Tel:806-376-1741
Fax:806-376-9301
Email:abi@amarbio.com
WWW:

www.amarbio.com/index.htm




Recent Publications by Amarillo Biosciences Incorporated:

Systemic effects of interferons after oral administration in animals and humans.
A gene (mdlA) encoding mono- and diacylglycerol lipase (MDGL) from...
1st March, 2005
Amarillo Biosciences Inc, 4134 Business Park Dr, Amarillo, TX 79110, USA. Am J Vet Res. 2005 Jan;66(1):164-76.
Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
OBJECTIVE: This study tested the safety and efficacy of human interferon...
1st October, 2003
Amarillo Biosciences, Inc., Amarillo, Texas 79101, USA. Arthritis Rheum. 2003 Aug 15;49(4):585-93.
DOI Direct Link
A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjogren's syndrome.
OBJECTIVES: To examine the safety and efficacy of anhydrous crystalline...
4th March, 2003
Amarillo Biosciences, Incorporated, Amarillo, TX, USA. J Altern Complement Med. 2002 Oct;8(5):651-9.
DOI Direct Link

BioNews Results for Amarillo Biosciences Incorporated:

Form 4 AMARILLO BIOSCIENCES For: Jul 10 Filed by: MUELLER PETER ROBERT
Street Insider:  Jul 11 2008 2:39PM Matching: amarillo biosciences
Form 4 AMARILLO BIOSCIENCES For: Jul 10 Filed by: Cummins Martin Joseph
Street Insider:  Jul 10 2008 11:08PM Matching: amarillo biosciences
Form 4 AMARILLO BIOSCIENCES For: Jul 10 Filed by: CUMMINS JOSEPH M
Street Insider:  Jul 10 2008 10:12PM Matching: amarillo biosciences
Form 4 AMARILLO BIOSCIENCES For: Jun 02 Filed by: MUELLER PETER ROBERT
Street Insider:  Jun 16 2008 10:11PM Matching: amarillo biosciences
Amarillo Biosciences announces filing of patent for obesity drug
M2:  Jun 12 2008 3:15PM Matching: amarillo biosciences
Promote your company here: BioNewsCast - Press Release Distribution

View more Amarillo Biosciences Incorporated news.

Amarillo Biosciences Incorporated Patents:

US Patent No.Title
6656920 Composition and method for promoting oral health
6506377 Interferon-alpha mediated upregulation of aquaporin expression
6036949 Treatment of fibromyalgia with low doses of interferon

Amarillo Biosciences Incorporated (AMAR.OB) Financial information Links from Barchart

AMAR.OB Quote from from Barchart.com
AMAR.OB Chart from from Barchart.com
AMAR.OB Profile from from Barchart.com
AMAR.OB Opinion from from Barchart.com

View more Amarillo Biosciences Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 331 times since April 2007, the link to the organisation's website has been followed 4 times

Recent Search Terms used to find this page: amar amarillo bio quote | Amarillo Biosciences | behcet syndrome | amarillo bio | .

Search for more companies in Amarillo

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Amarillo Biosciences Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.